Daniel Caballero is a Director of Global Operations at Amgen, having recently led the drug substance technology transfer for etesevimab. Between 2021 and 2023, Daniel served as Director of Process Development, overseeing purification sciences and engineering. With extensive experience in process development and commercial operations, Daniel has contributed to significant yield increases across multiple drug substance franchises. Daniel holds a Ph.D. in Chemistry (Biochemistry, Biophysics) and a B.S. in Chemistry and Biology, both from the University of Puerto Rico-Rio Piedras.
This person is not in the org chart
This person is not in any teams
This person is not in any offices